We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Biosensor Provides Improved Ricin Detection

By Biotechdaily staff writers
Posted on 14 Mar 2006
An improved cartridge has been produced for a ricin handheld detector that virtually eliminates false-positive results. More...


Ricin is a protein derived from the bean of the castor oil plant. It is a potent toxin that has the potential to be used as an agent of biologic warfare and as a weapon of mass destruction.

The detection system is simple, robust, and reliable and was designed for civilian and military first responders, hospital triage personnel, and Haz Mat (hazardous material) personnel. This QTL Biosensor 2000 from QTL Biosystems (Sante Fe, NM, USA) includes tests for toxins such as ricin, botulinum neurotoxin, Staphyloccocal enterotoxin B, pathogens such as anthrax spores, and other threatening agents.

The QTL technology is relatively sensitive, fast, simple, and easy to use, with low rates of false-positives and false-negatives. The QTL Biosensor was developed and tested in conjunction with the U.S. Army Edgewood Chemical Biological Command (Washington, DC, USA) to validate its performance specifications. It has also been rigorously tested by third party agencies to validate its performance. Richard Troiano, CEO of QTL Biosystems, noted, "The QTL Biosensor provides a reliable ‘Yes' or ‘No' answer to a field responder in less than five minutes without the risk of the high degree of false-positives seen in lateral flow assays.”

QTL Biosystems produces enzyme activity and protein binding assays for the pharmaceutical and life sciences markets, and Biosensor Systems for first responders, medical triage personnel, and military users. Bioassay products have been developed for the detection of viruses, toxins, bacteria, proteins, hormones, nucleic acids, and other biologic compounds. The company's novel technologies integrate its expertise in chemistry, molecular and cell biology, and instrumentation.



Related Links:
QTL Biosystems

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Nasopharyngeal Applicator
CalgiSwab 5.5" Sterile Mini-tip Calcium Alginate Nasopharyngeal Swab w/Aluminum HDLE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.